| http://www.w3.org/ns/prov#value | - We have many opportunities to grow our business, including the continued commercialization of XGEVA?? and Prolia?? and expansion into emerging markets and Japan, which we believe may offset the adverse financial impact of our principal products?? patent expiries.
|
